Cargando…

Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital

Due to Coronavirus disease (COVID-19) a new group of patients at risk emerged with COVID-19-associated mucormycosis (CAM). Systematic studies, evaluating the prevalence of CAM are missing. To assess CAM prevalence in a tertiary care hospital in Germany, we applied direct microscopy, fungal culture a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scharmann, Ulrike, Herbstreit, Frank, Steckel, Nina Kristin, Dedy, Jutta, Buer, Jan, Rath, Peter-Michael, Verhasselt, Hedda Luise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953274/ https://www.ncbi.nlm.nih.gov/pubmed/35330309 http://dx.doi.org/10.3390/jof8030307

Ejemplares similares

COVID‐19‐associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates
por: Kirchhoff, Lisa, et al.
Publicado: (2022)

COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany
por: Verhasselt, Hedda L., et al.
Publicado: (2021)

Microbiological Non-Culture-Based Methods for Diagnosing Invasive Pulmonary Aspergillosis in ICU Patients
por: Scharmann, Ulrike, et al.
Publicado: (2023)

Antibacterial Activity of the Novel Drug Gepotidacin against Stenotrophomonas maltophilia—An In Vitro and In Vivo Study
por: Sanders, Maike Isabell, et al.
Publicado: (2022)

Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience
por: Dubler, Simon, et al.
Publicado: (2022)

P357 Update on risk factors for Candida krusei-Fungemia
por: Jansen, Julia C., et al.
Publicado: (2022)

Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study
por: Verhasselt, Hedda Luise, et al.
Publicado: (2023)

Evaluation of Three Commercial PCR Assays for the Detection of Azole-Resistant Aspergillus fumigatus from Respiratory Samples of Immunocompromised Patients
por: Scharmann, Ulrike, et al.
Publicado: (2021)

Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro
por: Beck, Sascha, et al.
Publicado: (2019)

Phenotypical Characteristics of the Black Yeast Exophiala dermatitidis Are Affected by Pseudomonas aeruginosa in an Artificial Sputum Medium Mimicking Cystic Fibrosis–Like Conditions
por: Kirchhoff, Lisa, et al.
Publicado: (2020)

Acid Ceramidase Rescues Cystic Fibrosis Mice from Pulmonary Infections
por: Becker, Katrin Anne, et al.
Publicado: (2021)

Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study
por: Totzeck, Andreas, et al.
Publicado: (2021)

Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India
por: Chavan, Reshma P., et al.
Publicado: (2022)

A Case-Control Study on Mucormycosis in Tertiary Care Hospital, Bhopal
por: Toppo, Manju, et al.
Publicado: (2022)

Otorhinolaryngological presentations of mucormycosis amid COVID-19 pandemic in a tertiary care hospital
por: Fazal-I-Wahid,, et al.
Publicado: (2022)

Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital
por: Kamath, Sangita, et al.
Publicado: (2022)

P295 Overview of post-covid mucormycosis in a tertiary care hospital in South India
por: Sridhar, Kripa
Publicado: (2022)

COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series
por: Singh, Shivam, et al.
Publicado: (2022)

Anaesthetic concerns in post-COVID mucormycosis at a tertiary care hospital in India: An observational study
por: Lahiri, Swati, et al.
Publicado: (2023)

Quality of life in patients treated for COVID-19–associated mucormycosis at a tertiary care hospital
por: Kumar, Pragya, et al.
Publicado: (2023)

The Study of Clinical Profile of Patients With Mucormycosis During COVID-19 Pandemic in Tertiary Care Hospital
por: Kumar, Santosh, et al.
Publicado: (2023)

Substantial heterogeneity of inflammatory cytokine production and its inhibition by a triple cocktail of toll-like receptor blockers in early sepsis
por: Buys, Willem, et al.
Publicado: (2023)

Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections
por: Schnitker, Fabian, et al.
Publicado: (2023)

Hospital-acquired gangrenous mucormycosis.
por: Patterson, J. E., et al.
Publicado: (1986)

Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series
por: Singh, Yudhyavir, et al.
Publicado: (2021)

COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India
por: Rashbi K., Shafeedha, et al.
Publicado: (2022)

Secondary Cutaneous Mucormycosis – Retrospective Analysis From Tertiary Care Hospitall
por: Arora, Nikhil, et al.
Publicado: (2023)

Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital
por: Kumari, Abha, et al.
Publicado: (2021)

P365 Upsurge of Mucormycosis in COVID-19—a retrospective study in a tertiary care hospital in Punjab
por: Mohan, Sangeetha
Publicado: (2022)

Perioperative Challenges in the Management of Rhino-Orbital Cerebral Mucormycosis: An Observational Study from a Tertiary Care Hospital
por: Bhalerao, Pradnya Milind, et al.
Publicado: (2022)

Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study
por: Irfan, Ayesha, et al.
Publicado: (2023)

Epidemiology of mucormycosis in post-COVID-19 patients treated in a tertiary care hospital, Visakhapatnam, Andhra Pradesh
por: Manda, Venkata Vijayasekhar, et al.
Publicado: (2022)

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study
por: Kontoyiannis, Dimitrios P., et al.
Publicado: (2016)

Medical studies in times of a pandemic – concepts of digital teaching for Orthopaedics and Trauma at german universities
por: Mielke, Anna-Maria, et al.
Publicado: (2023)

Unsuspected invasive neonatal gastrointestinal mucormycosis: A clinicopathological study of six cases from a tertiary care hospital
por: Patra, Sushma, et al.
Publicado: (2012)

Experience on rhino-orbital mucormycosis from a tertiary care hospital in the first wave of COVID-19: An Indian perspective
por: Saluja, Gunjan, et al.
Publicado: (2022)

Postoperative clinical nursing care pathway for patients with mucormycosis: An experience from a tertiary care hospital in Rajasthan, India
por: Kalal, Nipin, et al.
Publicado: (2021)

P299 A clinicomycological study of suspected mucormycosis in post-COVID patients attending a tertiary care hospital
por: Tak, Kiran, et al.
Publicado: (2022)

Management of post-COVID mucormycosis at a tertiary care center in Northern India
por: Pathak, Lav, et al.
Publicado: (2023)

In Vitro and In Vivo Effect of the Imidazole Luliconazole against Lomentospora prolificans and Scedosporium spp.
por: Furnica, Dan-Tiberiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ik5561668ql12ntv7ckrr2kv8l